Advanced Biofabrication Technologies
The new frontiers of regenerative medicine
The regenerative medicine represents one of the greatest challenges of modern medicine.
With Electrospider we use cells taken from the patient to bioprinting perfectly functioning organs and modeled from the anatomy of the patient.
This allows resolve the problems related to the limited availability of organs for transplants and the related anti-hygiene issues that the patient must be subjected to for the rest of his life.
Our solution
Our offer is aimed at pharmaceutical and cosmetic companies, hospitals, clinics and laboratories, research centers and universities in Italy and abroad, and includes the sale of Electrospider, protocols of use, contracts for 3D bioprinting services, customer care, training and research and development contracts.
Our technology hub
The 3D printer that we use to achieve anatomical prototypes, are located in our technological center a few kilometers from Firenze.

Advanced Biofabrication Technologies
Read the latest news

Workshop Electrospider: un’immersione nell’ecosistema della biostampa multiscala e multimateriale
Un incontro di alto livello per esplorare le potenzialità della biostampa nei laboratori di ricerca.

3D bioprinting revolutionizes medicine
3D printing of diseased organs opens new frontiers in surgery: Electrospider’s contribution to humanitas’ medical research

SolidWorld Group: spedita la biostampante Electrospider a un prestigioso ospedale svizzero
Prosegue la distribuzione su scala mondiale della prima piattaforma di medicina rigenerativa personalizzata tridimensionale per la ricerca oncologica e la creazione di tessuti umani impiantabili.